© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Andy Studna
Articles
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
September 06, 2024
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.